EFFECT OF VON WILLEBRAND FACTOR ON THE ASSAY OF FACTOR-VIII CONCENTRATE

被引:0
|
作者
MIURA, Y [1 ]
机构
[1] NATL INST HLTH,DEPT BLOOD PROD,TOKYO 141,JAPAN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1318 / 1318
页数:1
相关论文
共 50 条
  • [31] PROPHYLAXIS WITH FACTOR-VIII VON-WILLEBRAND-FACTOR CONCENTRATE AS SUPPORT OF HIGH-RISK PREGNANCY IN A WOMAN AFFECTED BY SEVERE VON-WILLEBRAND DISEASE
    CIAVARELLA, N
    SCHIAVONI, M
    ETTORRE, C
    FASANO, A
    STEFANILE, C
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1172 - 1172
  • [32] RECOMBINANT FACTOR-VIII CONCENTRATE
    WALKER, I
    POON, MC
    LANCET, 1992, 339 (8784): : 61 - 62
  • [33] FACTOR-VIII CONCENTRATE - HEPATITIS
    ANDES, WA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (17): : 2331 - 2331
  • [34] Factor VIII and von Willebrand factor
    Vlot, AJ
    Koppelman, SJ
    Bouma, BN
    Sixma, JJ
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (03) : 456 - 465
  • [35] Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.
    Mannucci, PM
    Kyrle, PA
    Schulman, S
    Haertel, S
    Lethagen, S
    BLOOD, 2003, 102 (11) : 312A - 312A
  • [36] Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?
    Drillaud, Nicolas
    Ardillon, Laurent
    Ternisien, Catherine
    Valentin, Jean Baptiste
    Trossaert, Marc
    TRANSFUSION MEDICINE REVIEWS, 2020, 34 (02) : 128 - 129
  • [37] Efficacy and safety of factor VIII/von Willebrand factor concentrate Haemate P in von Willebrand patients undergoing surgery
    Zotz, R.
    Mandaliev, A.
    Moeller, N.
    Scharf, R.
    HAEMOPHILIA, 2008, 14 : 118 - 118
  • [39] Acquired von-Willebrand factor and factor-VIII deficiencies caused by angiostrongylosis in a dog
    Hausmann, Lisa
    Pack, Alexander
    Hausmann, Sylvia
    Neiger, Reto
    TIERAERZTLICHE PRAXIS AUSGABE KLEINTIERE HEIMTIERE, 2016, 44 (03): : 189 - 193
  • [40] Accumulation of factor VIII and von Willebrand factor during prophylaxis with a plasma-derived von Willebrand FACTOR/FACTOR VIII concentrate during the WIL-31 study
    Kateryna, V. V.
    Vdovin, V.
    Timofeeva, M. A.
    Khayat, C. D.
    Inati, A.
    Sidonio, R. F., Jr.
    HAEMOPHILIA, 2024, 30 : 139 - 140